Related Experiment Video
Updated: May 10, 2026

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry
Published on: July 13, 2019
The human polyomavirus BK (BKPyV): virological background and clinical implications
Christine Hanssen Rinaldo1, Garth D Tylden, Biswa Nath Sharma
1Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway. christine.rinaldo@unn.no
Polyomavirus BK (BKPyV) causes lifelong urinary tract infections. While asymptomatic in most, it leads to severe disease like polyomavirus-associated nephropathy (PyVAN) and hemorrhagic cystitis (PyVHC) in immunocompromised individuals.
Area of Science:
- Virology
- Immunology
- Nephrology
Background:
- Polyomavirus BK (BKPyV) establishes lifelong infections in the human genitourinary tract.
- Infection is typically asymptomatic in immunocompetent individuals but can reactivate.
- Reactivation in immunocompromised patients causes severe diseases like PyVAN and PyVHC.
Purpose of the Study:
- To summarize current knowledge on BKPyV infection.
- To highlight the clinical manifestations and diagnostic methods for BKPyV-associated diseases.
- To discuss the challenges in treating BKPyV infections.
Main Methods:
- Review of existing literature on BKPyV.
- Summary of diagnostic techniques including qPCR, cytology, and histology.
- Analysis of treatment strategies for BKPyV-associated nephropathy and hemorrhagic cystitis.
Main Results:
- BKPyV reactivation leads to significant morbidity in transplant recipients.
- Diagnosis relies on viral load detection and tissue examination.
- Current management focuses on immune modulation for PyVAN and supportive care for PyVHC.
Conclusions:
- Effective antiviral therapies for BKPyV are lacking.
- Managing BKPyV complications requires careful monitoring of immunocompromised patients.
- Further research is needed to develop targeted antiviral treatments.
More Related Videos
06:21Quantitative Fluorescence In Situ Hybridization (FISH) and Immunofluorescence (IF) of Specific Gene Products in KSHV-Infected Cells
Published on: August 27, 2019
07:10Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus
Published on: August 15, 2025
Related Concept Videos
Retroviruses
Viral Hepatitis I: Introduction
Human Virome
Mechanisms of Retrovirus-induced Cancers